About Us
CRISPRomics®
+
CRISPRomics®
Publications
Pipeline
+
Pipeline®
Expanded Access Policy
News
People
+
Leadership Team
Board of Directors
Careers
Contact
Follow us on Twitter
Find us on LinkedIn
2022 HNSCC SITC Poster
November 11, 2022
“Manufacture of KSQ-001, a CRISPR/Cas9-engineered TIL (
e
TIL®) therapy, for the treatment of Head and Neck Squamous Cell Carcinoma”
© 2023 KSQ Therapeutics, Inc. All rights reserved.